T-CELL LEUKEMIA/LYMPHOMA, ADULT
Clinical trials for T-CELL LEUKEMIA/LYMPHOMA, ADULT explained in plain language.
Never miss a new study
Get alerted when new T-CELL LEUKEMIA/LYMPHOMA, ADULT trials appear
Sign up with your email to follow new studies for T-CELL LEUKEMIA/LYMPHOMA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial aims to stop cancer before it starts in High-Risk patients
Prevention Recruiting nowThis study is testing whether the drug mogamulizumab can prevent a serious type of blood cancer called adult T-cell leukemia/lymphoma (ATL) from developing. It is for people who carry the HTLV-1 virus and have specific changes in their immune cells that put them at high risk for …
Matched conditions: T-CELL LEUKEMIA/LYMPHOMA, ADULT
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Mar 27, 2026 12:38 UTC
-
Scientists hunt for weak spots in stubborn blood cancers
Knowledge-focused Recruiting nowThis study aims to find new drug combinations that can kill hard-to-treat T-cell leukemia and lymphoma cells. Researchers will test how cancer cells from patients respond to different drug mixes in the lab. The goal is to identify promising treatments for future testing, not to d…
Matched conditions: T-CELL LEUKEMIA/LYMPHOMA, ADULT
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC